These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 8475631)

  • 21. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The possibility that pancreatic beta cell destruction leading to type 1 diabetes is initiated by the release of cytokines by polyclonal activation of the immune system.
    Ziegler M; Ziegler B
    Exp Clin Endocrinol; 1990 Feb; 95(1):110-8. PubMed ID: 2139848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Type I diabetes mellitus: immunopathogenesis and chances of primary immunotherapy].
    Ziegler AG; Standl E
    Med Klin (Munich); 1987 Oct; 82(22):796-800. PubMed ID: 3316970
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of beta cell maturity in the development of type I diabetes mellitus.
    Granot M; Perlman R; Sprecher E; Tenenbaum G; Barzilai D; Vardi P
    Isr J Med Sci; 1994 Mar; 30(3):22-5. PubMed ID: 8181921
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.
    Ichinose K; Kawasaki E; Eguchi K
    Am J Nephrol; 2007; 27(6):554-64. PubMed ID: 17823503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Which factors cause type-1 diabetes?].
    Akerblom HK
    Nord Med; 1992; 107(8-9):204-6, 230. PubMed ID: 1408724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies to prevent type 1 diabetes.
    Thrower SL; Bingley PJ
    Diabetes Obes Metab; 2009 Oct; 11(10):931-8. PubMed ID: 19476469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of autoimmunity in insulin-dependent diabetes mellitus.
    Bach JF
    Clin Exp Immunol; 1988 Apr; 72(1):1-8. PubMed ID: 3293847
    [No Abstract]   [Full Text] [Related]  

  • 29. [Autoimmunity and glutamate decarboxylase antibodies in the pathogenesis of type I diabetes mellitus in experimental and clinical practice].
    Kucera P; Andĕl M; Treslová L
    Vnitr Lek; 1996 May; 42(5):359-67. PubMed ID: 8768297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
    Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of Type 1 diabetes mellitus.
    Friday RP; Trucco M; Pietropaolo M
    Diabetes Nutr Metab; 1999 Feb; 12(1):3-26. PubMed ID: 10517302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H; Formby B
    Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of the pathogenesis of beta-cell destruction in insulin-dependent diabetes mellitus.
    Lernmark A; Bärmeier H; Dube S; Hagopian W; Karlsen AE; Markholst H; Wilson C; Wassmuth R
    West J Med; 1990 Nov; 153(5):499-502. PubMed ID: 1979704
    [No Abstract]   [Full Text] [Related]  

  • 34. The accelerator hypothesis and increasing incidence of type 1 diabetes.
    Fourlanos S; Harrison LC; Colman PG
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):321-5. PubMed ID: 18594271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus.
    Muir A; Schatz DA; Maclaren NK
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early intervention in insulin-dependent diabetes mellitus.
    Cahill GF
    Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin-dependent diabetes mellitus as an autoimmune disease.
    Bach JF
    Endocr Rev; 1994 Aug; 15(4):516-42. PubMed ID: 7988484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in diabetology: diabetic dermopathy, autoantibodies in the prediction of the development of type 1 diabetes, and islet cell transplantation and inhaled insulin as treatment for diabetes.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2006 Nov; 31(6):837-40. PubMed ID: 16907932
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diabetes caused by insulin-receptor antibodies. Autoimmune diabetes caused by anti-islands of Langerhans immunity].
    Boitard C; Timsit J; Assan R; Bach JF
    Rev Prat; 1986 Dec; 36(59-60):3500-4. PubMed ID: 3544174
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diabetes and immunology. II. Role of autoimmunity in the precipitation of diabetes].
    Ekoe JM; Albert J
    Sem Hop; 1983 Jun; 59(22):1705-7. PubMed ID: 6308796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.